Interos vs VaxCare: Revenue, Funding & Team size compared. Interos generates $39.7M in revenue; VaxCare generates $37.4M. Interos and VaxCare are close to the same size by revenue. The table below compares Interos and VaxCare on funding, valuation, customers, team size and headquarters - every figure GetLatka has verified for each company. | Company | InterosThis company | VaxCare | | Revenue | $39.7M | $37.4M | | Valuation | $1B | Not disclosed | | Funding raised | $128.4M | Not disclosed | | Customers | 500 | Not disclosed | | Team size | 167 | 340 | | Founded | 2005 | 2007 | | HQ | Arlington, United States | Orlando, United States | Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews. Interos at a glance. Interos generates $39.7M in revenue with 167 employees, headquartered in Arlington, United States. * Revenue - $39.7M * Valuation - $1B * Funding - $128.4M * Customers - 500 * Team size - 167 * Founded - 2005 Combining innovative big data analytics with best in class insights, the Interos Eco-system Mapping, Monitoring and Assurance platform creates a holistic picture of our customers' ecosystem and individual suppliers. Through our cloud-based... VaxCare at a glance. VaxCare generates $37.4M in revenue with 340 employees, headquartered in Orlando, United States. * Revenue - $37.4M * Team size - 340 * Founded - 2007 We build technology to manage every aspect of vaccinations, start to finish. From complete inventory visibility and automated replenishment to daily immunization highlights, we make it easy for providers to get back to doing what they do... Other Interos alternatives. Interos competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category. Interos vs VaxCare: frequently asked questions. Is Interos or VaxCare bigger? Interos is the bigger company by revenue, at $39.7M against $37.4M for VaxCare. How much revenue does Interos make? Interos generates $39.7M in annual revenue with a team of 167. How much revenue does VaxCare make? VaxCare generates $37.4M in annual revenue with a team of 340. How much funding has Interos raised? Interos has raised $128.4M in total funding since it was founded in 2005.

Interos.ai has launched i Q, a predictive analytics platform designed to help Fortune 1000 companies and government agencies quantify supply chain risks and financial exposure. The platform integrates enterprise resource planning data with the company's Resilience platform to provide AI-driven supply chain risk management suggestions. The initial release includes three modules: i tariffs, which maps current and anticipated tariffs and quantifies dollar impact; i tracing, offering multi-tier supplier network visibility; and i reputation, which surfaces reputational risks across supply chains. The platform matches ERP identifiers with interos.ai's knowledge graph to track sub-tier risks and suggest alternative suppliers. i Q enables organisations to communicate risks in financial terms whilst allowing seamless ERP workflow integration. The platform is currently available to select customers.

Interos.ai has launched iQ, a second-generation predictive analytics platform for supply chain risk management. The platform enables Fortune 1000 companies and government agencies to quantify financial exposure and receive AI-driven risk mitigation suggestions by integrating ERP data with interos.ai's knowledge graph. iQ initially offers three modules: iTariffs, which maps current and anticipated tariffs and quantifies dollar impact; iTracing, providing product-level supply chain risk visibility across multi-tier supplier networks; and iReputation, which surfaces reputational risks including adverse corporate behaviour and foreign influence risk. The platform helps organisations prioritise suppliers, assign owners and execute mitigation strategies whilst quantifying exposure in financial terms. iQ is currently available to select customers, with broader rollout planned.